...
...
Next Story

Government unveils draft of rare diseases policy, to focus on prevention

Published on: Jan 14, 2020, 01:52:29 IST
Hindustan Times, New Delhi | By
Prefer HTon Google
The All Indian Institute of Medical Sciences (AIIMS) in New Delhi   is one of the select government hospitals that will provide treatment for rare diseases. (HT File Photo)
The All Indian Institute of Medical Sciences (AIIMS) in New Delhi is one of the select government hospitals that will provide treatment for rare diseases. (HT File Photo)
Advertisement

The government estimates that about 6-8% of country’s population is affected by a rare disease

The Government on Monday put out the much awaited draft National Policy For Rare Diseases 2020 in public domain that proposes to provide up to 15 lakh for rare disease treatment to patients needing one-time treatment.

HT last month had reported that government was soon releasing the policy.

The list of beneficiaries includes all who are covered under the government’s flagship Ayushman Bharat scheme.

The proposal makes about 40% of the country’s population eligible for getting money under the special fund.

The government has also proposed to facilitate voluntary donations to fund the treatment by creating a dedicated digital platform. It will also notify select government hospitals that provide treatment for rare diseases that include Delhi’s AIIMS and Maulana Azad Medical College and SGPGI in Lucknow.

The government focus will also be on prevention and high risk pregnant women will be screened for possible diseases.

The Union health ministry had begun formulating the policy for treatment of rare diseases in 2017. However, it later decided to review the policy due to ‘implementation challenges’ and in view of new information and updates available for its further improvement and effective implementation.

Since India doesn’t know the exact burden of rare disease, it is estimated by the government applying international standards that about 6-8% of country’s population is affected by a rare disease.

 
ABOUT THE AUTHOR
Rhythma Kaul

Rhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.

Catch every big hit, every wicket with Crick-it, a one stop destination for Live Scores, Match Stats, Quizzes, Polls & much more. Explore now!.

Catch your daily dose of Fashion, Taylor Swift, Health, Festivals, Travel, Relationship, Recipe and all the other Latest Lifestyle News on Hindustan Times Website and APPs.
Catch every big hit, every wicket with Crick-it, a one stop destination for Live Scores, Match Stats, Quizzes, Polls & much more. Explore now!.

Catch your daily dose of Fashion, Taylor Swift, Health, Festivals, Travel, Relationship, Recipe and all the other Latest Lifestyle News on Hindustan Times Website and APPs.
SHARE THIS ARTICLE ON